Keep current on the latest news from Allegro Ophthalmics

Sign up today to be notified about the initiation of clinical trials, study results and breaking company news.

Your info will never be shared with a third-party

No Thanks

Clinical Trials


Allegro has a promising new therapy in development – Luminate® – that could potentially offer patients with some of the leading causes of blindness an improved quality of life sustained by self-sufficient, functional vision. Luminate® is in various stages of clinical development for multiple indications, including diabetic retinopathy, diabetic macular edema, wet age-related macular degeneration, and vitreomacular traction.

Currently, Allegro is enrolling patients into two clinical trials for the following indications: